[go: up one dir, main page]

EA200200853A1 - Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака - Google Patents

Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака

Info

Publication number
EA200200853A1
EA200200853A1 EA200200853A EA200200853A EA200200853A1 EA 200200853 A1 EA200200853 A1 EA 200200853A1 EA 200200853 A EA200200853 A EA 200200853A EA 200200853 A EA200200853 A EA 200200853A EA 200200853 A1 EA200200853 A1 EA 200200853A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
mtdk
application
compatible salts
cancer prevention
Prior art date
Application number
EA200200853A
Other languages
English (en)
Other versions
EA004592B1 (ru
Inventor
Руди Зузило
Ханс Роммельшпахер
Original Assignee
Руди Зузило
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Руди Зузило filed Critical Руди Зузило
Publication of EA200200853A1 publication Critical patent/EA200200853A1/ru
Publication of EA004592B1 publication Critical patent/EA004592B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к применению 2-метилтиазолидин-2,4-дикарбоновой кислоты (2-МТДК) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака.Отчет о международном поиске был опубликован 2002.05.30.
EA200200853A 2000-02-15 2001-02-15 Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака EA004592B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10008159A DE10008159B4 (de) 2000-02-15 2000-02-15 Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel
PCT/DE2001/000656 WO2001060343A2 (de) 2000-02-15 2001-02-15 Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen

Publications (2)

Publication Number Publication Date
EA200200853A1 true EA200200853A1 (ru) 2003-02-27
EA004592B1 EA004592B1 (ru) 2004-06-24

Family

ID=7631906

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200853A EA004592B1 (ru) 2000-02-15 2001-02-15 Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака

Country Status (15)

Country Link
US (2) US6943185B2 (ru)
EP (1) EP1255538B1 (ru)
JP (1) JP2003522782A (ru)
CN (1) CN1400899A (ru)
AT (1) ATE252383T1 (ru)
AU (1) AU783933B2 (ru)
CA (1) CA2399709C (ru)
DE (2) DE10008159B4 (ru)
EA (1) EA004592B1 (ru)
ES (1) ES2208571T3 (ru)
MX (1) MXPA02007903A (ru)
PL (1) PL357179A1 (ru)
PT (1) PT1255538E (ru)
TR (1) TR200302134T4 (ru)
WO (1) WO2001060343A2 (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050197406A1 (en) * 1999-04-14 2005-09-08 Li Chiang J. Method of treatment of lung cancer
DE10008159B4 (de) * 2000-02-15 2005-08-18 Rudy Dr. Susilo Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel
RU2293721C2 (ru) * 2002-02-28 2007-02-20 Джапан Тобакко Инк. Сложноэфирные соединения и их применение в медицине
WO2005021486A1 (ja) * 2003-08-29 2005-03-10 Japan Tobacco Inc. エステル誘導体及びその医薬用途
DE102004021658A1 (de) * 2004-05-03 2005-12-01 Rudy Dr. Susilo Kombinationspräparate enthaltend 2-Methylthiazolidin-2,4-dicarbonsäure
US20060030623A1 (en) * 2004-07-16 2006-02-09 Noboru Furukawa Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
US8101774B2 (en) * 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof
BRPI0516772A (pt) * 2004-10-25 2008-09-23 Japan Tobacco Inc formulação sólida com solubilidade e estabilidade melhoradas e método para produção da referida formulação
JP5439849B2 (ja) * 2008-02-28 2014-03-12 味の素株式会社 システイン誘導体
JP5378713B2 (ja) * 2008-06-19 2013-12-25 日本理化学薬品株式会社 外用組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19711053C2 (de) 1997-03-03 1999-09-02 Rommelspacher Kombinationspräparat aus 2-Methyl-thiazolidin-2,4-dicarbonsäure und Paracetamol
DE19711052C2 (de) * 1997-03-03 1999-09-23 Hans Rommelspacher Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure als Mukolytikum
DE10008159B4 (de) * 2000-02-15 2005-08-18 Rudy Dr. Susilo Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel

Also Published As

Publication number Publication date
DE10008159B4 (de) 2005-08-18
CA2399709C (en) 2007-05-15
US20030149085A1 (en) 2003-08-07
EA004592B1 (ru) 2004-06-24
EP1255538B1 (de) 2003-10-22
CA2399709A1 (en) 2001-08-23
US6943185B2 (en) 2005-09-13
AU3919001A (en) 2001-08-27
WO2001060343A3 (de) 2002-05-30
WO2001060343A2 (de) 2001-08-23
EP1255538A2 (de) 2002-11-13
AU783933B2 (en) 2005-12-22
PL357179A1 (en) 2004-07-26
TR200302134T4 (tr) 2004-01-21
CN1400899A (zh) 2003-03-05
PT1255538E (pt) 2004-03-31
MXPA02007903A (es) 2004-09-10
DE10008159A1 (de) 2001-09-06
ATE252383T1 (de) 2003-11-15
JP2003522782A (ja) 2003-07-29
US20050187271A1 (en) 2005-08-25
DE50100833D1 (de) 2003-11-27
ES2208571T3 (es) 2004-06-16

Similar Documents

Publication Publication Date Title
DE60023043T2 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
EA200501095A1 (ru) Фенилацетамиды и их применение в качестве модуляторов глюкокиназы
MXPA03007140A (es) Derivados de carbolina.
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
SE0102315D0 (sv) Compounds
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
ATE376832T1 (de) Verzögert freisetzende formulierungen von oxymorphon
PT1349856E (pt) Compostos de isoindolina-1-ona activadores da glicocinase
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
NO20014560L (no) Quinasoliner og terapautisk anvendelse derav
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE50310516D1 (de) Fredericamycin-derivate
CY1109229T1 (el) Χρηση σπογγοσινης (2-μεθοξυαδενοσινης) για τη θεραπεια πονου, συγκεκριμενα υπερευαισθησιας στο πονο
DE60216233D1 (en) Carbolinderivate
NO20040516L (no) Kombinasjonsterapi for behandling av kreft.
SE0101932D0 (sv) Pharmaceutical combinations
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
MXPA04005809A (es) Inhibidores de proteinas quinasas.
DE60128100D1 (de) Analgetisches arzneimittel
PT1051187E (pt) Tratamento de linfomas foliculares usando inibidores da via da linfotoxina (lt)
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
ITTO20000441A0 (it) Composizione terapeutica per la cura della psoriasi.
SE0004827D0 (sv) Therapeutic compounds

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM